Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2013 1
2014 1
2016 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Combined targeting of EGFR and HER2 against prostate cancer stem cells.
Rossini A, Giussani M, Ripamonti F, Aiello P, Regondi V, Balsari A, Triulzi T, Tagliabue E. Rossini A, et al. Among authors: aiello p. Cancer Biol Ther. 2020 May 3;21(5):463-475. doi: 10.1080/15384047.2020.1727702. Epub 2020 Feb 23. Cancer Biol Ther. 2020. PMID: 32089070 Free PMC article.
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
Forte L, Turdo F, Ghirelli C, Aiello P, Casalini P, Iorio MV, D'Ippolito E, Gasparini P, Agresti R, Belmonte B, Sozzi G, Sfondrini L, Tagliabue E, Campiglio M, Bianchi F. Forte L, et al. Among authors: aiello p. BMC Cancer. 2018 May 23;18(1):586. doi: 10.1186/s12885-018-4500-9. BMC Cancer. 2018. PMID: 29792166 Free PMC article.
Radiation effects on development of HER2-positive breast carcinomas.
Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T, Sozzi G, Fossati-Bellani F, Ménard S, Tagliabue E. Castiglioni F, et al. Among authors: aiello p. Clin Cancer Res. 2007 Jan 1;13(1):46-51. doi: 10.1158/1078-0432.CCR-06-1490. Clin Cancer Res. 2007. PMID: 17200337
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M. Turdo F, et al. Among authors: aiello p. Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935. Oncotarget. 2016. PMID: 27626701 Free PMC article.
Immunological and pathobiological roles of fibulin-1 in breast cancer.
Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, Agresti R, Aiello P, Invernizzi A, Baldassari P, Twal WO, Mortarini R, Anichini A, Ménard S. Pupa SM, et al. Among authors: aiello p. Oncogene. 2004 Mar 18;23(12):2153-60. doi: 10.1038/sj.onc.1207323. Oncogene. 2004. PMID: 14691454